204
Participants
Start Date
August 31, 2002
Primary Completion Date
August 31, 2003
Study Completion Date
August 31, 2003
MCC-135
MCC-135 50 mg, tablets, orally, twice daily for up to 12 weeks
MCC-135
MCC-135 100 mg, tablets, orally, once daily for up to 12 weeks
MCC-135
MCC-135 200 mg, tablets, orally, once daily for up to 12 weeks
Placebo
MCC-135 placebo-matching tablets, orally, once daily for up to 12 weeks
Saint Vincent Catholic Medical Center, New York
Albert Einstein College of Medicine, The Bronx
Hudson Valley Clinical Research, Kingston
Heart Care Center East, Fayetteville
Buffalo General Hospital, Buffalo
University of Rochester, Rochester
University of Pittsburgh Medical Center, Pittsburgh
Chestnut Hill Cardiology, Ltd., Flourtown
Cardiovascular Consultants, PA, Takoma Park
Cardiology Associates, PC, Annapolis
University of Maryland Hospital, Baltimore
Cardiovascular Associates, Ltd., Chesapeake
Carolina Research Associates, Columbia
Medical University of South Carolina, Charleston
Southern Clinical Research & Management, Augusta
Cardiology Consultants PA, Daytona Beach
Jacksonville Center for Clinical Research, Jacksonville
Cardiology Associates of Fort Lauderdale, Fort Lauderdale
Cardiovascular Center of Sarasota, Sarasota
The Stern Cardiovascular Center, Memphis
Medical Center Cardiologist, Louisville
Louisville Cardiology Medical Group, PSC, Louisville
North Ohio Research, Ltd., Lorain
City Cardiology Associates, Inc., Stow
Sterling Research Group, Cincinnati
Medical Group of Fort Wayne, PC, Fort Wayne
University of Michigan, Ann Arbor
Henry Ford Health System, Detroit
Henry Ford Hospital, Detroit
Wisconsin Center for Clinical Research, LLC, Elkhorn
Alegent Health Immanuel Medical Center, Omaha
Bryan LGH Heart Institute, Lincoln
Louisiana Heart Center, Chalmette
New Orleans Center for Clinical Research, New Orleans
Ochsner Clinic, New Orleans
Cardiac Center of Louisiana, LLC, Shreveport
Cardiovascular Research Institute of Dallas Medical Center - Cardiologist Research Foundation, Dallas
Tyler Cardiovascular Consultants, Tyler
Med-Tech Research, Houston
Nassau Bay
Maricopa Medical Center, Phoenix
University of Arizona Medical Center, Tucson
ARI Clinical Trials, Inc Arrhythmia Research & Cardiology Health Center, Redondo Beach
LAC & USC Medical Center, Los Angeles
San Diego Cardiovascular, Encinitas
University of California San Diego, San Diego
Apex Research Institute, Santa Ana
Capitol Intervention Cardiology, Carmichael
Clinical Trials Research, Roseville
Sacramento Heart & Vascular Medical Associates, Sacramento
University of Massachusettes, Worcester
Millburn
South Jersey Heart Group, Sewell
Lead Sponsor
Takeda
INDUSTRY